Medinotec (MDNC) EBT Growth (1y) (2023 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | Medinotec | - | - | 854,557.00 | -114.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -114.20% |
| Nov 30, 2025 | 12.72% |
| Aug 31, 2025 | 32.54% |
| May 31, 2025 | 22.71% |
| Feb 28, 2025 | 928.63% |
| Nov 30, 2024 | 212.14% |
| Aug 31, 2024 | 1,376.33% |
| May 31, 2024 | 953.91% |
| Feb 29, 2024 | 361.55% |
| Nov 30, 2023 | -2,458.54% |
| Aug 31, 2023 | 85.53% |
| May 31, 2023 | 124.22% |
| Feb 28, 2023 | 62.17% |